Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 155

1.

Transformation to small cell lung cancer as a mechanism of resistance to immunotherapy in non-small cell lung cancer.

Bar J, Ofek E, Barshack I, Gottfried T, Zadok O, Kamer I, Urban D, Perelman M, Onn A.

Lung Cancer. 2019 Oct 1;138:109-115. doi: 10.1016/j.lungcan.2019.09.025. [Epub ahead of print]

PMID:
31683093
2.

Whole exome sequencing in childhood-onset lupus frequently detects single gene etiologies.

Tirosh I, Spielman S, Barel O, Ram R, Stauber T, Paret G, Rubinsthein M, Pessach IM, Gerstein M, Anikster Y, Shukrun R, Dagan A, Adler K, Pode-Shakked B, Volkov A, Perelman M, Greenberger S, Somech R, Lahav E, Majmundar AJ, Padeh S, Hildebrandt F, Vivante A.

Pediatr Rheumatol Online J. 2019 Jul 30;17(1):52. doi: 10.1186/s12969-019-0349-y.

3.

Comparative effectiveness of intensity modulated radiation therapy to 3-dimensional conformal radiation in locally advanced lung cancer: pathological and clinical outcomes.

Appel S, Bar J, Ben-Nun A, Perelman M, Alezra D, Urban D, Ben-Ayun M, Honig N, Ofek E, Katzman T, Onn A, Chatterji S, Dubinski S, Tsvang L, Felder S, Kraitman J, Haisraely O, Rabin Alezra T, Lieberman S, Marom EM, Golan N, Simansky D, Symon Z, Lawrence YR.

Br J Radiol. 2019 May;92(1097):20180960. doi: 10.1259/bjr.20180960. Epub 2019 Apr 1.

PMID:
30864828
4.

Sex Coaching for Non-Sexologist Physicians: How to Use the Sexual Tipping Point Model.

Perelman MA.

J Sex Med. 2018 Dec;15(12):1667-1672. doi: 10.1016/j.jsxm.2018.10.010. No abstract available.

PMID:
30527051
5.

Metastatic cardiac tumors: from clinical presentation through diagnosis to treatment.

Burazor I, Aviel-Ronen S, Imazio M, Goitein O, Perelman M, Shelestovich N, Radovanovic N, Kanjuh V, Barshack I, Adler Y.

BMC Cancer. 2018 Feb 20;18(1):202. doi: 10.1186/s12885-018-4070-x.

6.

Neo-adjuvant Chemo-Radiation to 60 Gray Followed by Surgery for Locally Advanced Non-Small Cell Lung Cancer Patients: Evaluation of Trimodality Strategy.

Appel S, Goldstein J, Perelman M, Rabin T, Urban D, Onn A, Shulimzon TR, Weiss I, Lieberman S, Marom EM, Golan N, Simansky D, Ben-Nun A, Lawrence YR, Bar J, Symon Z.

Isr Med Assoc J. 2017 Oct;19(10):614-619.

7.

Opinion Paper: On the Diagnosis/Classification of Sexual Arousal Concerns in Women.

Althof SE, Meston CM, Perelman MA, Handy AB, Kilimnik CD, Stanton AM.

J Sex Med. 2017 Nov;14(11):1365-1371. doi: 10.1016/j.jsxm.2017.08.013. Epub 2017 Sep 22.

PMID:
28958593
8.

Toward a More Evidence-Based Nosology and Nomenclature for Female Sexual Dysfunctions-Part II.

Parish SJ, Goldstein AT, Goldstein SW, Goldstein I, Pfaus J, Clayton AH, Giraldi A, Simon JA, Althof SE, Bachmann G, Komisaruk B, Levin R, Spadt SK, Kingsberg SA, Perelman MA, Waldinger MD, Whipple B.

J Sex Med. 2016 Dec;13(12):1888-1906. doi: 10.1016/j.jsxm.2016.09.020. Epub 2016 Nov 11.

PMID:
27843072
9.

Psychosexual therapy for delayed ejaculation based on the Sexual Tipping Point model.

Perelman MA.

Transl Androl Urol. 2016 Aug;5(4):563-75. doi: 10.21037/tau.2016.07.05. Review.

10.

Reexamining the Definitions of PE and DE.

Perelman MA.

J Sex Marital Ther. 2017 Oct 3;43(7):633-644. doi: 10.1080/0092623X.2016.1230161. Epub 2016 Sep 3.

PMID:
27594579
11.

Efficacy, safety, and tolerability of fentanyl pectin nasal spray in patients with breakthrough cancer pain.

Ueberall MA, Lorenzl S, Lux EA, Voltz R, Perelman M.

J Pain Res. 2016 Aug 17;9:571-85. doi: 10.2147/JPR.S106177. eCollection 2016.

12.

New ARCHITECT plasma pro-gastrin-releasing peptide assay for diagnosing and monitoring small-cell lung cancer.

Nisman B, Nechushtan H, Biran H, Peled N, Gantz-Sorotsky H, Doviner V, Perelman M, Bar J, Onn A, Uziely B, Peretz T.

Br J Cancer. 2016 Feb 16;114(4):469-76. doi: 10.1038/bjc.2016.7. Epub 2016 Jan 26.

13.

Factors Related to the Intention of Israelis to Use Complementary and Alternative Medicine.

Ben Natan M, Perelman M, Ben-Naftali G.

J Holist Nurs. 2016 Dec;34(4):361-368. Epub 2015 Nov 29.

PMID:
26620812
14.

IgG4-Related Lung Disease - Three Untreated Cases with a Benign Outcome.

Baltaxe E, Shulimzon T, Lieberman S, Rozenman J, Perelman M, Segel MJ.

Arch Bronconeumol. 2016 Jan;52(1):e1-3. doi: 10.1016/j.arbres.2015.07.017. Epub 2015 Oct 9. English, Spanish.

15.

Etanercept-Induced Pneumonitis: Severe Complication of Tumor Necrosis Factor-Alpha Blocker Treatment.

Watad A, Perelman M, Mansour R, Shoenfeld Y, Amital H.

Isr Med Assoc J. 2015 Feb;17(2):130-2. No abstract available.

16.

Fentanyl pectin nasal spray for breakthrough cancer pain.

Torres LM, Trinidad JM, Calderón E, Benitez D, Perelman M.

Int J Palliat Nurs. 2015 Mar;21(3):114-6. doi: 10.12968/ijpn.2015.21.3.114. No abstract available.

PMID:
25815759
17.

Treatment satisfaction of men and partners following switch from on-demand phosphodiesterase type 5 inhibitor therapy to tadalafil 5 mg once daily.

Burns PR, Rosen RC, Dunn M, Baygani SK, Perelman MA.

J Sex Med. 2015 Mar;12(3):720-7. doi: 10.1111/jsm.12818. Epub 2015 Jan 23.

PMID:
25615445
18.

Relationship between onset of pain relief and patient satisfaction with fentanyl pectin nasal spray for breakthrough pain in cancer.

Torres LM, Revnic J, Knight AD, Perelman M.

J Palliat Med. 2014 Oct;17(10):1150-7. doi: 10.1089/jpm.2014.0089. Epub 2014 Sep 11.

PMID:
25211772
19.

An analysis of the variability of breakthrough pain intensity in patients with cancer.

Burton AW, Filbet M, Knight AD, Tayi R, Perelman M.

J Community Support Oncol. 2014 Mar;12(3):99-103.

PMID:
24971415
20.

The unique clinical features and outcome of infectious endocarditis and vertebral osteomyelitis co-infection.

Koslow M, Kuperstein R, Eshed I, Perelman M, Maor E, Sidi Y.

Am J Med. 2014 Jul;127(7):669.e9-669.e15. doi: 10.1016/j.amjmed.2014.02.023. Epub 2014 Mar 6.

PMID:
24608019
21.

Genetic mutation screen in early non--small-cell lung cancer (NSCLC) specimens.

Bar J, Damianovich M, Hout Siloni G, Dar E, Cohen Y, Perelman M, Ben Nun A, Simansky D, Yellin A, Urban D, Onn A.

Clin Lung Cancer. 2014 Mar;15(2):159-65. doi: 10.1016/j.cllc.2013.11.005. Epub 2013 Nov 14.

PMID:
24370118
22.

Chitosan: a promising safe and immune-enhancing adjuvant for intranasal vaccines.

Smith A, Perelman M, Hinchcliffe M.

Hum Vaccin Immunother. 2014;10(3):797-807. Epub 2013 Dec 17. Review.

23.

A report on the long-term use of fentanyl pectin nasal spray in patients with recurrent breakthrough pain.

Taylor D, Radbruch L, Revnic J, Torres LM, Ellershaw JE, Perelman M.

J Pain Symptom Manage. 2014 Jun;47(6):1001-7. doi: 10.1016/j.jpainsymman.2013.07.012. Epub 2013 Oct 12.

PMID:
24128821
24.

A pharmacokinetic assessment of an alternate titration strategy for fentanyl pectin nasal spray.

Perelman M, Knight A.

Int J Clin Pharmacol Ther. 2013 Dec;51(12):942-7. doi: 10.5414/CP201913.

PMID:
24120713
25.

BNF recommendations for the treatment of Wernick's encephalopathy: lost in translation?

Donovan A, Perelman M.

Alcohol Alcohol. 2013 Nov-Dec;48(6):743. doi: 10.1093/alcalc/agt145. Epub 2013 Sep 18. No abstract available.

PMID:
24049154
26.

Considerations in selecting rapid-onset opioids for the management of breakthrough pain.

Perelman M, Leake S.

J Pain Res. 2013 Jun 5;6:435-6. doi: 10.2147/JPR.S45774. Print 2013. No abstract available.

27.

A psychological perspective on male rejuvenation.

Miner MM, Perelman MA.

Fertil Steril. 2013 Jun;99(7):1803-6. doi: 10.1016/j.fertnstert.2013.04.044. Review.

PMID:
23726253
28.

Patient highlights. Delayed ejaculation.

Perelman MA.

J Sex Med. 2013 Apr;10(4):1189-90. doi: 10.1111/jsm.12141. No abstract available.

PMID:
23551543
29.

Comment: intranasal fentanyl spray: a novel dosage form for the treatment of breakthrough cancer pain.

Perelman M, Leake S.

Ann Pharmacother. 2013 Mar;47(3):428. doi: 10.1345/aph.1R069b. Epub 2013 Mar 5. No abstract available.

PMID:
23463744
30.

Impact of allergic rhinitis and its treatment on the pharmacokinetics of nasally administered fentanyl.

Perelman M, Fisher AN, Smith A, Knight A.

Int J Clin Pharmacol Ther. 2013 May;51(5):349-56. doi: 10.5414/CP201825.

PMID:
23458227
31.

Nasal delivery of fentanyl.

Watts P, Smith A, Perelman M.

Drug Deliv Transl Res. 2013 Feb;3(1):75-83. doi: 10.1007/s13346-012-0078-y.

PMID:
25787867
32.

Resection and heated pleural chemoperfusion in patients with thymic epithelial malignant disease and pleural spread: a single-institution experience.

Yellin A, Simansky DA, Ben-Avi R, Perelman M, Zeitlin N, Refaely Y, Ben-Nun A.

J Thorac Cardiovasc Surg. 2013 Jan;145(1):83-7; discussion 87-9. doi: 10.1016/j.jtcvs.2012.10.013. Epub 2012 Oct 27.

33.

Standard operating procedures for taking a sexual history.

Althof SE, Rosen RC, Perelman MA, Rubio-Aurioles E.

J Sex Med. 2013 Jan;10(1):26-35. doi: 10.1111/j.1743-6109.2012.02823.x. Epub 2012 Sep 12. Review.

PMID:
22970717
34.

Development of in vitro models to demonstrate the ability of PecSys®, an in situ nasal gelling technology, to reduce nasal run-off and drip.

Castile J, Cheng YH, Simmons B, Perelman M, Smith A, Watts P.

Drug Dev Ind Pharm. 2013 May;39(5):816-24. doi: 10.3109/03639045.2012.707210. Epub 2012 Jul 17.

35.

Skin rash, dyspnea, weight loss and leg edema in a 59 year old woman with amyloidosis.

Babaev M, Perelman M, Barzilai A, Mouallem M.

Isr Med Assoc J. 2012 Mar;14(3):202-3. No abstract available.

36.

The controversial role of phosphodiesterase type 5 inhibitors in the treatment of premature ejaculation.

Jannini EA, McMahon C, Chen J, Aversa A, Perelman M.

J Sex Med. 2011 Aug;8(8):2135-43. doi: 10.1111/j.1743-6109.2011.02401.x.

PMID:
21791006
37.

Low testosterone associated with obesity and the metabolic syndrome contributes to sexual dysfunction and cardiovascular disease risk in men with type 2 diabetes.

Wang C, Jackson G, Jones TH, Matsumoto AM, Nehra A, Perelman MA, Swerdloff RS, Traish A, Zitzmann M, Cunningham G.

Diabetes Care. 2011 Jul;34(7):1669-75. doi: 10.2337/dc10-2339. Review. No abstract available.

38.

Erectile dysfunction and depression: screening and treatment.

Perelman MA.

Urol Clin North Am. 2011 May;38(2):125-39. doi: 10.1016/j.ucl.2011.03.004. Review.

PMID:
21621079
39.

The Subjective Sexual Arousal Scale for Men (SSASM): preliminary development and psychometric validation of a multidimensional measure of subjective male sexual arousal.

Althof SE, Perelman MA, Rosen RC.

J Sex Med. 2011 Aug;8(8):2255-68. doi: 10.1111/j.1743-6109.2011.02319.x. Epub 2011 May 19.

PMID:
21595840
40.

Commentary on the DSM-V considerations regarding premature ejaculation.

Perelman MA.

J Sex Marital Ther. 2011;37(2):145-50. doi: 10.1080/0092623X.2011.547358. No abstract available.

PMID:
21400338
41.

Mesothelioma and asbestosis in a young woman following occupational asbestos exposure: Short latency and long survival: Case Report.

Bitchatchi E, Kayser K, Perelman M, Richter ED.

Diagn Pathol. 2010 Dec 16;5:81. doi: 10.1186/1746-1596-5-81.

42.

Men with ED also report changes in orgasmic sensations.

Perelman MA.

J Androl. 2011 May-Jun;32(3):340; author reply 341-2. doi: 10.2164/jandrol.110.011619. Epub 2010 Oct 7. No abstract available.

PMID:
20930190
43.

A diagnostic assay based on microRNA expression accurately identifies malignant pleural mesothelioma.

Benjamin H, Lebanony D, Rosenwald S, Cohen L, Gibori H, Barabash N, Ashkenazi K, Goren E, Meiri E, Morgenstern S, Perelman M, Barshack I, Goren Y, Edmonston TB, Chajut A, Aharonov R, Bentwich Z, Rosenfeld N, Cohen D.

J Mol Diagn. 2010 Nov;12(6):771-9. doi: 10.2353/jmoldx.2010.090169. Epub 2010 Sep 23.

44.

Editorial comment.

Perelman MA.

Urology. 2010 Jun;75(6):1363-4. doi: 10.1016/j.urology.2009.12.023. No abstract available.

PMID:
20513495
45.

Comments on "Considerations for a better definition of male orgasmic disorder in DSM V".

Wylie K, Ralph D, Levin RJ, Corona G, Perelman MA.

J Sex Med. 2010 Feb;7(2 Pt 1):695-9. doi: 10.1111/j.1743-6109.2009.01683_1.x. No abstract available.

PMID:
20492419
46.

Comments on "Considerations for an evidence-based definition of premature ejaculation in the DSM-V".

Morales A, Zargooshi J, Jern P, McCullough A, Hellstrom W, Shamloul R, Bella AJ, Becher EF, Rubio-Aurioles E, Perelman MA, Palmer N, Rothman M.

J Sex Med. 2010 Feb;7(2 Pt 1):679-89. doi: 10.1111/j.1743-6109.2009.01682_1.x. No abstract available.

PMID:
20492417
47.

MicroRNA expression differentiates between primary lung tumors and metastases to the lung.

Barshack I, Lithwick-Yanai G, Afek A, Rosenblatt K, Tabibian-Keissar H, Zepeniuk M, Cohen L, Dan H, Zion O, Strenov Y, Polak-Charcon S, Perelman M.

Pathol Res Pract. 2010 Aug 15;206(8):578-84. doi: 10.1016/j.prp.2010.03.005. Epub 2010 Apr 24.

PMID:
20418022
48.

A novel translocation breakpoint within the BPTF gene is associated with a pre-malignant phenotype.

Buganim Y, Goldstein I, Lipson D, Milyavsky M, Polak-Charcon S, Mardoukh C, Solomon H, Kalo E, Madar S, Brosh R, Perelman M, Navon R, Goldfinger N, Barshack I, Yakhini Z, Rotter V.

PLoS One. 2010 Mar 11;5(3):e9657. doi: 10.1371/journal.pone.0009657.

49.

Standards for clinical trials in sexual dysfunction in women: research designs and outcomes assessment.

Clayton AH, Dennerstein L, Fisher WA, Kingsberg SA, Perelman MA, Pyke RE.

J Sex Med. 2010 Jan;7(1 Pt 2):541-60. doi: 10.1111/j.1743-6109.2009.01628.x. Review.

PMID:
20092452
50.

Reliability of efficacy in men with erectile dysfunction treated with tadalafil once daily after initial success.

Shabsigh R, Donatucci C, Costabile R, Perelman MA, Burns P, Zeigler H, Wong DG.

Int J Impot Res. 2010 Jan-Feb;22(1):1-8. doi: 10.1038/ijir.2009.29. Epub 2009 Aug 6.

PMID:
19657349

Supplemental Content

Loading ...
Support Center